| Segment Reporting [Text Block] |
The Chief Operating Decision Maker is the Chief Executive Officer, who reviews the segment operating results in order to allocate resources and assess performance.
The Company has identified four segments:
(1) Electric vehicles,
(2) Medical supplies,
(3) Artificial Intelligence ("AI") Infrastructure, and
(4) Drones.
The electric vehicle segment consists of sales of commercial electric vehicles to customers. A significant portion of such sales are through state subsidized or funded programs. The medical supplies segment consists solely of sales to Maddox Medical, a related party based on an agreement to supply refurbished medical gowns on a cost-plus pricing arrangement. Through the Company's drone operations, it is also diversifying its portfolio of assets by engaging in the future production and supply of drones that will be used in the agricultural environment as well as engaging in AI activities. Currently, activity within the drones segment is limited to start up expenses and research and development activities. AI expenses are primarily lease expenses.
The tables below summarizes the operating results of the Company's segments for the three and six months ended June 30, 2026 and June 30, 2025:
| | | Three months ended June 30, 2026 | |
| | | Electric vehicles | | | Medical Supplies | | | AI Data Infrastructure | | | Drones | | | Corporate | | | Total | |
| Sales, net | | $ | - | | | $ | 2,662,887 | | | $ | - | | | $ | - | | | $ | - | | | $ | 2,662,887 | |
| Operating Income (Loss) | | $ | (205,381 | ) | | $ | (133,282 | ) | | $ | (148,000 | ) | | $ | - | | | $ | (5,250,437 | ) | | $ | (5,737,100 | ) |
| Interest income (expense), net | | | | | | | | | | | | | | | | | | | | | | | - | |
| Loss on conversion and changes in fair value of convertible notes | | | | | | | | | | | | | | | | | | | | | | | (893,630 | ) |
| Other expense | | | | | | | | | | | | | | | | | | | | | | | (6,686 | ) |
| Income tax expense | | | | | | | | | | | | | | | | | | | | | | | - | |
| Net loss | | | | | | | | | | | | | | | | | | | | | | $ | (6,637,416 | ) |
| | | Three months ended June 30, 2025 | |
| | | Electric vehicles | | | Medical Supplies | | | AI Data Infrastructure | | | Drones | | | Corporate | | | Total | |
| Sales, net | | $ | (25,237 | ) | | $ | 1,072,266 | | | $ | - | | | $ | - | | | $ | - | | | $ | 1,047,029 | |
| Operating loss | | $ | (3,274,582 | ) | | $ | (951,437 | ) | | $ | - | | | $ | (573,607 | ) | | $ | - | | | $ | (4,799,626 | ) |
| Interest income (expense), net | | | | | | | | | | | | | | | | | | | | | | | 303 | |
| Loss on conversion and changes in fair value of convertible notes | | | | | | | | | | | | | | | | | | | | | | | (366,908 | ) |
| Other expense | | | | | | | | | | | | | | | | | | | | | | | 19,494 | |
| Income tax expense | | | | | | | | | | | | | | | | | | | | | | | - | |
| Net loss | | | | | | | | | | | | | | | | | | | | | | $ | (5,146,737 | ) |
| | | Six months ended June 30, 2026 | |
| | | Electric vehicles | | | Medical Supplies | | | AI Data Infrastructure | | | Drones | | | Corporate | | | Total | |
| Sales, net | | $ | - | | | $ | 4,911,508 | | | $ | - | | | $ | - | | | $ | - | | | $ | 4,911,508 | |
| Operating Income (Loss) | | $ | (426,877 | ) | | $ | (178,271 | ) | | $ | (197,333 | ) | | $ | (10,000 | ) | | $ | (8,695,668 | ) | | $ | (9,508,149 | ) |
| Interest income (expense), net | | | | | | | | | | | | | | | | | | | | | | | 50 | |
| Loss on conversion and changes in fair value of convertible notes | | | | | | | | | | | | | | | | | | | | | | | (1,000,627 | ) |
| Other expense | | | | | | | | | | | | | | | | | | | | | | | (115,613 | ) |
| Income tax expense | | | | | | | | | | | | | | | | | | | | | | | - | |
| Net loss | | | | | | | | | | | | | | | | | | | | | | $ | (10,624,339 | ) |
| | | Six months ended June 30, 2025 | |
| | | Electric vehicles | | | Medical Supplies | | | AI Data Infrastructure | | | Drones | | | Corporate | | | Total | |
| Sales, net | | $ | 348,063 | | | $ | 1,289,532 | | | $ | - | | | $ | - | | | $ | - | | | $ | 1,637,595 | |
| Operating loss | | $ | (16,524,991 | ) | | $ | (1,339,675 | ) | | $ | - | | | $ | (666,634 | ) | | $ | - | | | $ | (18,531,300 | ) |
| Interest income (expense), net | | | | | | | | | | | | | | | | | | | | | | | 11,056 | |
| Loss on conversion and changes in fair value of convertible notes | | | | | | | | | | | | | | | | | | | | | | | (650,701 | ) |
| Other expense | | | | | | | | | | | | | | | | | | | | | | | (12,173 | ) |
| Income tax expense | | | | | | | | | | | | | | | | | | | | | | | - | |
| Net loss | | | | | | | | | | | | | | | | | | | | | | $ | (19,183,118 | ) |
|